1-(Pyrimidin-2-yl)thiourea → HCID 46836790, compound
Reaction equation
Br[C:2]1(Br)[CH2:10][C:9]([CH3:12])([CH3:11])[C:8]2[NH:7][N:6]=[CH:5][C:4]=2[C:3]1=O.[N:15]1[CH:20]=[CH:19][CH:18]=[N:17][C:16]=1[NH:21][C:22]([NH2:24])=[S:23]>C(O)C>[CH3:11][C:9]1([CH3:12])[C:8]2[NH:7][N:6]=[CH:5][C:4]=2[C:3]2[N:24]=[C:22]([NH:21][C:16]3[N:17]=[CH:18][CH:19]=[CH:20][N:15]=3)[S:23][C:2]=2[CH2:10]1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
According to Scheme 2 Step 4: A solution of 5,5-dibromo-7,7-dimethyl-6,7-dihydro-1H-indazol-4(5H)-one (6.09 mmol, 1.96 g) and of 1-(pyrimidin-2-yl)thiourea (6.09 mmol, 939 mg) in ethanol (18 mL) was microwaved at 150° C. for 90 minutes and then at 140° C. for 40 minutes. After filtration, the reaction mixture was concentrated to dryness. The crude residue was partitioned between DCM and a saturated solution of Na2CO3. The aqueous phase was extracted with DCM. The organic phase was dried over Na2SO4 and concentrated. The crude residue was purified by flash chromatography over silica gel using DCM/MeOH (98:2 to 90:10) as eluent to yield 5,5-dimethyl-N-(pyrimidin-2-yl)-5,6-dihydro-4H-thiazolo[4,5-e]indazol-2-amine (90 mol, 27 mg) as a brown solid.
Workup
- filtrationAfter filtration
- concentrationthe reaction mixture was concentrated to dryness
- customThe crude residue was partitioned between DCM
- extractionThe aqueous phase was extracted with DCM
- dry with materialThe organic phase was dried over Na2SO4
- concentrationconcentrated
- customThe crude residue was purified by flash chromatography over silica gel
Sources & evidence
- ORD record
- ord-336628e580c74cbfb64a46093f3ebddb
- Source dataset
- uspto-grants-2014_04
- Patent number
- US08697744B2
Reaction notes
Loading…